NO985573L - Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose - Google Patents
Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporoseInfo
- Publication number
- NO985573L NO985573L NO985573A NO985573A NO985573L NO 985573 L NO985573 L NO 985573L NO 985573 A NO985573 A NO 985573A NO 985573 A NO985573 A NO 985573A NO 985573 L NO985573 L NO 985573L
- Authority
- NO
- Norway
- Prior art keywords
- osteoporosis
- cyclic
- growth hormone
- coherence
- absorbent
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 125000004122 cyclic group Chemical group 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 239000002250 absorbent Substances 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010067572 Oestrogenic effect Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ny fremgangsmåte for behandling eller forhindring av utbrudd av osteoporose hos et dyr, f eks et pattedyr, særlig et menneske, som omfatter syklisk administrering til individet av en Veksthormonkomponent eventuelt supplert med kontinuerlig administrering av et medikament med østrogen effekt og/eller et medikament med gestagen effekt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK62396 | 1996-05-31 | ||
PCT/DK1997/000239 WO1997046252A1 (en) | 1996-05-31 | 1997-05-29 | Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO985573D0 NO985573D0 (no) | 1998-11-27 |
NO985573L true NO985573L (no) | 1999-01-29 |
Family
ID=8095682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO985573A NO985573L (no) | 1996-05-31 | 1998-11-27 | Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0907374A1 (no) |
JP (1) | JP2000512274A (no) |
KR (1) | KR20000016204A (no) |
CN (1) | CN1220609A (no) |
AU (1) | AU3025997A (no) |
BR (1) | BR9709499A (no) |
CA (1) | CA2257174A1 (no) |
CZ (1) | CZ383298A3 (no) |
HU (1) | HUP9904049A3 (no) |
IL (1) | IL126983A0 (no) |
NO (1) | NO985573L (no) |
PL (1) | PL330239A1 (no) |
WO (1) | WO1997046252A1 (no) |
ZA (1) | ZA974785B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HN1996000101A (es) | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
US6784158B1 (en) | 1998-06-09 | 2004-08-31 | Novo Nordisk A/S | Method for preparing a compound with growth hormone releasing properties |
EP1093463A1 (en) * | 1998-06-09 | 2001-04-25 | Novo Nordisk A/S | A method for preparing a compound with growth hormone releasing properties |
JP2001031635A (ja) | 1999-07-14 | 2001-02-06 | Ajinomoto Co Inc | 光学活性n−保護−n−メチル−フェニルアラニン誘導体の製造方法 |
DE60140285D1 (de) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EA200901077A1 (ru) | 2007-02-09 | 2010-04-30 | Транзим Фарма, Инк. | Макроциклические модуляторы грелинового рецептора и их применение |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ236618A (en) * | 1990-01-03 | 1997-06-24 | Ciba Geigy Ag | Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound |
DE69125394T2 (de) * | 1990-11-26 | 1997-08-21 | Robert R. Omaha Nebr. Recker | Behandlung von osteoporose unter verwendung von wachstumshormon-freisetzendem faktor (grf) in verbindung mit parathyroidhormon (pth) |
KR960705575A (ko) * | 1993-10-19 | 1996-11-08 | 도나 엘. 폴락 | 비스포스포네이트와 성장 호르몬 분비촉진제와의 배합물(Combination of bishosphonates and growth hormone secretagogues) |
-
1997
- 1997-05-29 CN CN97195144A patent/CN1220609A/zh active Pending
- 1997-05-29 IL IL12698397A patent/IL126983A0/xx unknown
- 1997-05-29 HU HU9904049A patent/HUP9904049A3/hu unknown
- 1997-05-29 CZ CZ983832A patent/CZ383298A3/cs unknown
- 1997-05-29 JP JP10500108A patent/JP2000512274A/ja active Pending
- 1997-05-29 EP EP97924934A patent/EP0907374A1/en not_active Withdrawn
- 1997-05-29 PL PL97330239A patent/PL330239A1/xx unknown
- 1997-05-29 KR KR1019980709772A patent/KR20000016204A/ko not_active Application Discontinuation
- 1997-05-29 CA CA002257174A patent/CA2257174A1/en not_active Abandoned
- 1997-05-29 AU AU30259/97A patent/AU3025997A/en not_active Abandoned
- 1997-05-29 BR BR9709499A patent/BR9709499A/pt not_active Application Discontinuation
- 1997-05-29 WO PCT/DK1997/000239 patent/WO1997046252A1/en not_active Application Discontinuation
- 1997-05-30 ZA ZA9704785A patent/ZA974785B/xx unknown
-
1998
- 1998-11-27 NO NO985573A patent/NO985573L/no unknown
Also Published As
Publication number | Publication date |
---|---|
PL330239A1 (en) | 1999-05-10 |
JP2000512274A (ja) | 2000-09-19 |
IL126983A0 (en) | 1999-09-22 |
AU3025997A (en) | 1998-01-05 |
ZA974785B (en) | 1998-01-22 |
CN1220609A (zh) | 1999-06-23 |
CZ383298A3 (cs) | 1999-07-14 |
NO985573D0 (no) | 1998-11-27 |
EP0907374A1 (en) | 1999-04-14 |
BR9709499A (pt) | 1999-08-10 |
CA2257174A1 (en) | 1997-12-11 |
KR20000016204A (ko) | 2000-03-25 |
WO1997046252A1 (en) | 1997-12-11 |
HUP9904049A3 (en) | 2000-07-28 |
HUP9904049A2 (hu) | 2000-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW366342B (en) | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss | |
WO2002041837A3 (en) | Treatment of mucositis | |
NO165547C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive androsta-1,4-dien-3,17-dioner. | |
DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
TJ242B (en) | A method of treatment an ovarian estrogen dependent condition | |
DK0946151T3 (da) | Doseringsform med stigende dosisfrigivelse | |
NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
DK1153610T3 (da) | Matrixproteinpræparater til inflammatoriske og infektiøse tilstande | |
NO985573L (no) | Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose | |
SE9603725D0 (sv) | New teatment | |
GB9103764D0 (en) | Compositions | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
HUP9802916A2 (hu) | Kozmetikai eljárás a bőröregedés jeleinek megelőzésére és kezelésére | |
NO20010390L (no) | Behandling av angstsykdommer | |
Bygdeman et al. | Medical termination of early pregnancy: the Swedish experience | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
NO985695L (no) | Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt | |
TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
Johnson et al. | Use of steel pins in hair transplantation | |
Meyers | Effectiveness vs. efficacy of antidepressants for the treatment of late-life depression: introduction to a retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older | |
UA31670A (uk) | Спосіб лікування синдрому після тотальної оваріектомії у жінок пери- та постменопаузального віку | |
ATE318612T1 (de) | Methoden und zusammensetzungen zur behandlung der hyperlipidämie | |
NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
UA7955A (uk) | Спосіб лікування туберкульозу легенів |